We are live on ! Find out more
EYEGW

Eyegate Pharmaceuticals, Inc. Warrants
EYEGW

Delisted

EYEGW was delisted on the 5th of August, 2020.

Back to rankings

5 hedge funds and large institutions have $390K invested in Eyegate Pharmaceuticals, Inc. Warrants in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

3% more capital invested

Capital invested by funds: $377K → $390K (+$13K)

0% more funds holding

Funds holding: 5 → 5 (0)

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ICM
Ionic Capital Management
New York
+$109K
2
BA
BlackRock Advisors
Delaware
+$34.2K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$21.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$131K -$21.7K -25,850 -13%
ICM
2
Ionic Capital Management
New York
$119K +$109K +130,400 +468%
AIC
3
AWM Investment Company
New York
$103K – – –
BA
4
BlackRock Advisors
Delaware
$35K +$34.2K +40,782 +691%
VIA
5
Vantage Investment Advisors
Pennsylvania
$2K – – –

EYEGW Hedge Fund Activity: Q4 2015 in Review

5 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Eyegate Pharmaceuticals, Inc. Warrants (EYEGW) for Q4 2015, worth a combined $390K — up 3.4% from $377K a quarter earlier.

Fund positioning in EYEGW was balanced in Q4 2015: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was Ionic Capital Management, adding an estimated $109K. The largest seller was Sabby Management, cutting an estimated $21.7K.

  • 5 institutional investors held Eyegate Pharmaceuticals, Inc. Warrants (EYEGW) as of Q4 2015, unchanged from Q3 2015.
  • Funds reported $390K of Eyegate Pharmaceuticals, Inc. Warrants stock for Q4 2015, up 3.4% quarter-over-quarter.
  • 0 funds opened new Eyegate Pharmaceuticals, Inc. Warrants positions in Q4 2015 and 0 closed out.
  • The largest Eyegate Pharmaceuticals, Inc. Warrants buyer in Q4 2015 was Ionic Capital Management, an estimated $109K added.
  • The largest Eyegate Pharmaceuticals, Inc. Warrants seller in Q4 2015 was Sabby Management, an estimated $21.7K sold.

Based on aggregated 13F filings for Q4 2015.